INSIGHTS ON CLINICAL TRIAL DESIGN

• How To Make Your Clinical Trial Protocol More IRT/RTSM Friendly?

  Simplifying and standardizing protocol elements strengthens RTSM builds by creating clear, repeatable structures that cut risk and boost reliability across the study lifecycle.

• Data Privacy And Trust In China's Clinical Trials

  China’s evolving privacy laws are reshaping how global trials operate. Sponsors that prioritize transparency and participant confidence can meet compliance demands while building lasting trust.

• Assessing Diversity In Early-Phase Clinical Trials In A Rapidly Changing Regulatory Environment

  Learn more about structuring early-phase trials to address population variation and the contributing factors to safe drug administration, both of which are essential to a drug development plan.

• Real-World Data Has Real Impact On Clinical Research

  The ultimate goal of using real-world data (RWD) in clinical research is to ensure a patient is on the right therapy and receiving the right care at the right point in their healthcare journey.

• 4 Proven Strategies To Optimize Patient Enrollment, Avoid Rescue Trials

  5/9/2025

  Though rescue studies are common, there are ample tactics to avoid these situations altogether, including robust planning, data analysis, and prioritization of patient recruitment and retention.

• Advancing Immunotherapy In Head And Neck Cancer: The IT-MATTERS Study

  4/17/2025

  This randomized controlled pivotal Phase 3 study evaluated efficacy and safety of neoadjuvant complex biologic administered for three consecutive weeks pre-surgery.

• Capital Efficiency In Cardiovascular Outcomes Trials

  7/8/2026

  New modeling shows aligning clinical and manufacturing operations in heart trials can cut costs, speed timelines, and boost expected program value.

• Advancing Dose Escalation Strategies With Bayesian Modeling

  8/12/2025

  A CRO was engaged to help a biotechnology sponsor develop a novel oncology therapy design and execute a multicenter, open-label Phase 1/2 dose escalation and expansion study in advanced solid tumors.

• Faster Trial Planning and Site Selection

  4/15/2025

  Address the challenges of identifying the most suitable trial sites and investigators while optimizing feasibility planning, reducing screen failure rates, and improving patient retention.